Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Cosmax Nbt Usa, Inc.
EIR
•Cosmax Nbt Usa, Inc.•November 22, 2019

Cosmax Nbt Usa, Inc. – FDA EIR, Nov 22, 2019

Record Details

A U.S. Food and Drug Administration (FDA) inspection of Cosmax NBT, a dietary supplement contract manufacturer in Garland, TX, was conducted from November 18 to November 22, 2019. The inspection assessed the firm's adherence to relevant Good Manufacturing Practices (GMP) regulations for dietary supplements, specifically compliance program 7321.008.

The inspection identified significant deviations, leading to a 15-item FDA Form 483. Key issues included systemic quality control failures, such as releasing dietary supplement batches that did not meet established product specifications and failing to reject components that did not meet their own specifications. The company also failed to perform appropriate identity testing for dietary ingredients, did not use scientifically valid testing methods, and lacked established specifications for finished product strength and component contamination. Furthermore, original records were not maintained, batch production records were incomplete, and quality control procedures were not consistently followed. Insufficient controls for automated equipment and a lack of review for required test results were also noted. A verbal observation highlighted that the firm's cannabidiol (CBD) products did not meet the definition of a dietary ingredient.

Cosmax NBT management committed to correcting these observations and providing a written response to the FDA within 15 business days.

Company
Cosmax Nbt Usa, Inc.
Inspection date
November 22, 2019
Product type
Dietary Supplements
Office
Dallas District Office
People
  • Justin A. Boyd (Research Specialist II)
  • Liza L. Quiles (investigator)
  • Rebecca Allen
View Company Profile

ID · 351cc7b2-75dc-4258-8c1a-075b4c97eb0b

Violation Codes10
21 CFR 111.123(b)(2)21 CFR 111.77(a)21 CFR 111.10321 CFR 111.75(c)21 CFR 111.75(a)(1)(i)21 CFR 111.75(h)(2)21 CFR 111.70(e)21 CFR 111.70(b)(3)21 CFR 111.70(b)(2)21 CFR 111.75(a)(2)(ii)(A)

Full citation text and observation details available on the Dashboard.

Other documents for Cosmax Nbt Usa, Inc.
  • WARNING_LETTER - 2021-05-04May 4, 2021
  • 483 - 2021-05-04May 4, 2021
  • 483 - 2019-11-22November 22, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cosmax Nbt Usa, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.